跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 520 条关于
“NYSE”
全部
520
临床试验
214
药物
0
机构
1
资讯
305
去年
Apimeds Pharmaceuticals Raises $13.5M in NYSE American IPO
8个月前
AstraZeneca Completes NYSE Direct Listing as EU Recommends Imfinzi for Gastric Cancer
去年
NanoViricides Advances NV-387 for Herpes Zoster Treatment to Phase II Trials
去年
NanoViricides Advances NV-387 to Phase II Trials Targeting MPox and Respiratory Infections
3个月前
SPDR S&P Pharmaceuticals ETF Outperforms Biotech Counterparts with Lower Costs and Stronger Returns
去年
Dr Ashleys Limited Acquires Impact BioMedical in Strategic Reverse Merger to Accelerate Global Drug Development
去年
OS Therapies to Present Phase 2b Osteosarcoma Trial Data at JP Morgan Healthcare Conference, Eyes $150M Priority Review Voucher
去年
Tech Innovations and Strategic Partnerships Highlight CES 2025
3个月前
Invesco Biotechnology & Genome ETF (PBE) Declares $0.8106 Dividend, Marking Significant Payout Increase
去年
Apimeds Pharmaceuticals Raises $13.5 Million in IPO for Bee Venom-Based Therapy Development
第 1 页,共 31 页
上一页
下一页